S. Tendolkar

发表

Evaluation of the Etest and Disk Diffusion Methods for Determining Susceptibilities of 235 Bloodstream Isolates of Candida glabrata to Fluconazole and Voriconazole

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.

Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

M. Pfaller, D. Diekema, S. Messer, 2009, Diagnostic microbiology and infectious disease.

Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values

M. Pfaller, D. Diekema, S. Messer, 2011, Journal of Clinical Microbiology.

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin

M. Pfaller, D. Diekema, S. Messer, 2010, Journal of Clinical Microbiology.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution

M. Pfaller, D. Diekema, S. Messer, 2010, Journal of Clinical Microbiology.

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles

M. Pfaller, D. Diekema, S. Messer, 2010, Journal of Clinical Microbiology.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

J. Turnidge, D. Diekema, R. Jones, 2009, Journal of Clinical Microbiology.

Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis

M. Pfaller, D. Diekema, S. Messer, 2005, Antimicrobial Agents and Chemotherapy.

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)

M. Pfaller, G. Doern, D. Diekema, 2005, Journal of Clinical Microbiology.

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.

M. Pfaller, D. Diekema, S. Messer, 2004, Diagnostic microbiology and infectious disease.

Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Methods

M. Pfaller, S. Messer, S. Tendolkar, 2006 .

Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Global Surveillance of In Vitro Activity of Micafungin against Candida: a Comparison with Caspofungin by CLSI-Recommended Methods

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

Cross-Resistance between Fluconazole and Ravuconazole and the Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Ravuconazole among 12,796 Clinical Isolates of Candida spp

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans, and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.

Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

Comparison of the Broth Microdilution Methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for Testing Itraconazole, Posaconazole, and Voriconazole against Aspergillus Isolates

M. Pfaller, D. Diekema, S. Messer, 2011, Journal of Clinical Microbiology.

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.

M. Pfaller, D. Diekema, S. Messer, 2010, Diagnostic microbiology and infectious disease.

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013

S. Richter, G. Doern, D. Diekema, 2016, Journal of Clinical Microbiology.

Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

Ronald N. Jones, M. Pfaller, D. Diekema, 2009, Diagnostic microbiology and infectious disease.

Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2011, Journal of Clinical Microbiology.

Evaluation of Etest and Disk Diffusion Methods Compared with Broth Microdilution Antifungal Susceptibility Testing of Clinical Isolates of Candida spp. against Posaconazole

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

Candidemia surveillance in Iowa: emergence of echinocandin resistance.

M. Castanheira, M. Pfaller, D. Diekema, 2014, Diagnostic microbiology and infectious disease.

Evaluation of Disk Diffusion and Etest Compared to Broth Microdilution for Antifungal Susceptibility Testing of Posaconazole against Clinical Isolates of Filamentous Fungi

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.

M. Pfaller, D. Diekema, S. Messer, 2004, Diagnostic microbiology and infectious disease.

Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study

S. Richter, G. Doern, D. Diekema, 2014, Infection Control & Hospital Epidemiology.

R. Platt, D. Warren, G. Zuccotti, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.